Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to increased histone acetylation, which could open up chromatin and result in the decreased transcription of OR9I1. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, potentially reducing DNA methylation at the OR9I1 gene locus, which could lead to a decrease in its mRNA and protein expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
By inhibiting histone deacetylases, Valproic Acid may enhance histone acetylation, potentially leading to a reduction in OR9I1 gene transcription levels. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid′s inhibition of histone deacetylases could decrease the transcription efficiency of the OR9I1 gene by altering chromatin accessibility. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, through its histone deacetylase inhibition, may promote histone acetylation, potentially leading to reduced transcriptional activity of the OR9I1 gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA, potentially obstructing transcription factor access and RNA polymerase activity at the OR9I1 gene, leading to reduced RNA synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and blocks RNA polymerase, potentially leading to a significant decrease in OR9I1 mRNA synthesis and subsequent protein production. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 reduces DNA methylation by inhibiting DNA methyltransferases, potentially leading to the decreased expression of methylation-silenced genes such as OR9I1. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine, by demethylating DNA, could decrease methylation at the OR9I1 gene promoter, potentially leading to a reduction in gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Through the inhibition of class I histone deacetylases, MS-275 may lead to decreased transcriptional activity of the OR9I1 gene by modifying chromatin states. | ||||||